Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases

Hepatology

Volumn 33, Issue 3, 2001, Pages 633-646

  Zollner, Gernot ^a   Fickert, Peter ^a   Zenz, Rainer ^b   Fuchsbichler, Andrea ^b   Stumptner, Conny ^b   Kenner, Lukas ^b   Ferenci, Peter ^c   Stauber, Rudolf E ^a   Krejs, Guenter J ^a   Denk, Helmut ^b   Zatloukal, Kurt ^b   Trauner, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOPHOSPHOLIPID; ANION; ASPARTATE AMINOTRANSFERASE; BILE SALT; BILIRUBIN; CARRIER PROTEIN; CATION; GAMMA GLUTAMYLTRANSFERASE; MESSENGER RNA; PHOSPHOLIPID; TAUROCHOLIC ACID;

ADULT; ALCOHOL LIVER DISEASE; ANTIBODY LABELING; ARTICLE; CHOLESTASIS; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; HEPATOBILIARY SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER DISEASE; OBSTRUCTIVE JAUNDICE; PATHOGENESIS; PERCUTANEOUS BIOPSY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE DISTRIBUTION; TRANSPORT KINETICS;

EID: 17744391290     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.22646     Document Type: Article

References (60)

1. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
2. Molecular aspects of hepatobiliary transport
3. Molecular pathogenesis of cholestasis
4. Molecular regulation of hepatocellular transport systems in cholestasis
5. Abnormal expression of anion exchanger genes in primary biliary cirrhosis
6. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis
7. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in exrahepatic biliary atresia
8. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene
9. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction
10. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY)
11. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
12. The simultaneous extraction of high molecular-weight DNA and RNA from solid tumors
13. Functions of c-jun in liver and heart developement
14. +/bile acid cotransporter
15. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1
16. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
17. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
18. Sequence of mdr3 cDNA encoding a human P-glycoprotein
19. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
20. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
21. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
22. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species
23. Current protocols in molecular medicine
24. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
25. The "megaprimer" method of site-directed mutagenesis
26. Molecular cloning: A laboratory manual
27. Technical aspects of quantitative competetive PCR
28. Disturbance of cytokeratin homeostasis in griseofulvin-intoxicated mouse liver
29. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver
30. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver
31. Absence of the canalicular isoform of the MRP gene encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
32. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
33. Defect of multidrug resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis
34. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
35. Assessment of biliary bicarbonate secretion in humans by positron emission tomography
36. Criteria of drug-induced liver disorders. Report of an international consensus meeting
37. Inflammation-induced cholestasis
38. Clinicopathology conferences: Inflammation-induced cholestasis
39. -/bile acid cotransporter in extrahepatic cholestasis
40. Effect of endotoxin on bile acid transport in rat liver: A potential model for sepsis-associated cholestasis
41. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters
42. Endotoxin downregulares rat hepatic ntcp gene expression via decreased activity of critical transcription factors
43. Interleukin-1 supresses retionoid transactivation of two hepatic transporter genes involved in bile formation
44. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1
45. +/taurocholate cotransporter is regulated in vivo by retention of biliary constituents but not their depletion
46. Identification of a nuclear receptor for bile acids
47. Targeted disruption of the nuclear receptor FXR/RXR impairs bile acid and lipid homeostasis
48. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promotor
49. The molecular expression of the bile salt export pump, sister of P-glycoprotein, is selectively preserved in cholestatic liver injury
50. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis
51. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver
52. Perturbation of NTCP, BSEP and MRP2 in human liver slices exposed to LPS
53. The molecular and immunohistochemical expression of multidrug resistance-associated protein (MRP3) in the liver and intestine of patients with cholestasis and its biological significance
54. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
55. MRP3, an organic anion transporter able to transportanti cancer drugs
56. Characterization of inducible nature of MRP3 in rat liver
57. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
58. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets
59. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone
60. Regulation of hepatocellular transporter expression depends on bile acid hydrophobicity in mice